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  The spontaneous axon regeneration of damaged neurons is limited after spinal cord injury (SCI). 
Recently, mesenchymal stem cell (MSC) transplantation was proposed as a potential approach for 
enhancing nerve regeneration that avoids the ethical issues associated with embryonic stem cell 
transplantation. As SCI is a complex pathological entity, the treatment of SCI requires a multipronged 
approach. The purpose of the present study was to investigate the functional recovery and therapeutic 
potential of human MSCs (hMSCs) and polymer in a spinal cord hemisection injury model. Rats were 
subjected to hemisection injuries and then divided into three groups. Two groups of rats underwent 
partial thoracic hemisection injury followed by implantation of either polymer only or polymer with 
hMSCs. Another hemisection-only group was used as a control. Behavioral, electrophysiological and 
immunohistochemical studies were performed on all rats. The functional recovery was significantly 
improved in the polymer with hMSC-transplanted group as compared with control at five weeks after 
transplantation. The results of electrophysiologic study demonstrated that the latency of somatosensory- 
evoked potentials (SSEPs) in the polymer with hMSC-transplanted group was significantly shorter than 
in the hemisection-only control group. In the results of immunohistochemical study, β -gal-positive cells 
were observed in the injured and adjacent sites after hMSC transplantation. Surviving hMSCs 
differentiated into various cell types such as neurons, astrocytes and oligodendrocytes. These data 
suggest that hMSC transplantation with polymer may play an important role in functional recovery 
and axonal regeneration after SCI, and may be a potential therapeutic strategy for SCI. 
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INTRODUCTION
  After spinal cord injury (SCI), failure of regeneration is 
attributed to the nonpermissive environment of the dam-
aged spinal cord. Injured spinal cord is characterized by 
astrocyte-derived inhibitory molecules in the scar tissue, 
demyelination of axons, lack of tropic support for axotom-
ized neurons, and intrinsic neuronal changes such as cell 
atrophy and death [1,2]. Therefore, effective repair strat-
egies for SCI require the creation of a permissive environ-
ment within the injured spinal cord in order to protect dam-
aged neurons from the effects of secondary injury and also 
to facilitate axonal regeneration. The repair of the injured 
human spinal cord in many cases requires neuronal surviv-
al, axonal growth and remyelination [3,4], as well as re-
connection across the trauma cavity by means of bridging 
grafts. 
  Clinically, the limited access to autologous donor materi-
als and the immunological problems associated with allog-
raft rejection have prompted a search for artificial bio-
materials that may be implanted as bridges in injured spi-
nal cords. Investigators have attempted to overcome some 
of these barriers by using implantable scaffolds made of 
a variety of materials, including biodegradable polymers 
and other, nondegradable materials [5,6]. Recent preclinical 
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studies include the implantation of tubes made from poly-
meric materials [7,8], polymer hydrogels [9-11] and bio-
degradable polylactide implants [12]. Although hydrogels, 
water-swollen insoluble polymers that can be made degrad-
able, have recently been used as scaffolds for axon re-
generation [13], their use in delivering molecules to pro-
mote regenerative growth in injured central nervous system 
has not been explored. Therefore, we expect that im-
plantation of the polymer with hMSC may be more efficient 
in improving functional recovery than implantation of the 
polymer alone.
  A variety of experimental strategies including stem cell 
transplantation are emerging to promote regeneration of in-
jured spinal cords. Mesenchymal stem cells (MSCs) con-
stitute an alternative source of pluripotent stem cells. They 
have the capacity to differentiate into cells of mesodermal 
lineage, and also have a much broader differentiation po-
tential [14-16]. After MSC transplantation into host CNS 
tissue, MSCs show the capacity to differentiate into neu-
rons [17-20] and astrocytes [21,22]. Recent studies have re-
ported that MSCs promote partial functional recovery after 
grafting to sites of SCI [23-25], although mechanisms un-
derlying this recovery have not been defined. Grafted MSCs 
survive in spinal cord tissue, forming cell bridges within 
the traumatic centromedullary cavity. In spinal cord tissue, 
cells expressing neuronal and astroglial markers have been 
observed, together with a marked ependymal proliferation 
and nestin-positivity, after MSC transplantation [26]. 
Moreover, MSC transplantation in a variety of animal mod-
els of SCI has been shown to produce remyelination and 
improved functional recovery [27-30]. Our previous reports 
have also shown that transplantation of human mesen-
chymal stem cells (hMSCs) into the spinal cord after con-
tusion injury promotes a functional outcome [31]. Thus, the 
present study was conducted to investigate the functional 
recovery and the therapeutic potential of human MSCs 
(hMSCs) and polymer in a spinal cord hemisection injury 
model using behavioral, electrophysiological and immuno-
histochemical evaluations. 
METHODS
Preparation of human mesenchymal stem cells 
  MSCs were cultured from the iliac crests of six normal 
patients between the ages of 10 and 15 years who had un-
dergone bone marrow harvests for future allogeneic trans-
plantation at the Ajou University Medical Center. Permis-
sion to use human MSCs was granted by the Institutional 
Review Board of Ajou University Medical Center, and all 
experiments were conducted with the understanding and 
written consent of each subject. Approximately 5 ml of bone 
marrow aspirates were centrifuged through a density gra-
dient and plated in culture media [31]. LacZ-expressing 
hMSCs were cultured in a 100-mm tissue culture Petri dish 
(Falcon, Franklin Lakes, NJ, USA) in Dulbecco's Modified 
Eagle's Medium (DMEM; Gibco, Grand Island, NY, USA) 
supplemented with 10% heat-inactivated standard fetal bo-
vine serum (FBS; HyClone, Logan, UT, USA), penicillin- 
streptomycin (Gibco), and 10 ng/ml bFGF (Sigma, St. Louis, 
MO, USA). The culture medium was changed every two 
days. After reaching confluency, the cells were harvested. 
Spinal cord hemisection injury and transplantation
  Male Sprague-Dawley rats (300∼350 g) were anesthe-
tized with pentobarbital (50 mg/kg, i.p.). Under microscopic 
observation, a laminectomy was conducted at vertebral lev-
els T10-11. After a longitudinal opening of the dura mater, 
a spinal cord hemisection was made at T11 spinal cord lev-
el, followed by the removal of 3 mm hemicord segment 
along the midline using micro-scissors (hemisection only 
group). Polymer (BDTM PuraMatrixTM Peptide Hydrogel, 
San Jose, CA, USA; polymer only group), polymer with 
hMSCs (4×105; polymer with hMSC group) was implanted 
into the cavity. The muscle and fascia were sutured and 
the skin was closed. Cyclosporine A (1 mg/100 g, i.p.) was 
injected daily starting two days before transplantation. 
Prophylactic gentamycin sulfate (1 mg/kg, i.m.) was regu-
larly administered for a week. All animal experiments were 
approved by the Institutional Animal Care and Use Com-
mittee of Yonsei University Health System. The number 
of animals used was kept to a minimum, and procedures 
were performed in a manner that minimized suffering.
Behavioral studies
  Motor function was tested using the BBB open field test-
ing procedure described by Basso et al. [32]. The BBB test 
on the injured leg side was performed 1 d, 4 d, and once 
a week from 1 to 8 weeks after the hemisection surgery. 
Sensory function was tested using mechanical thresholds 
and the up-and-down method [33]. The 50% paw with-
drawal threshold (PWT) to von Frey filament stimuli ap-
plied to the paw was measured and used as an indicator 
of mechanical sensitivity of the affected paw.
Electrophysiological studies
  Eight weeks after transplantation, the animals were re-
anesthetized with urethane (1.25 g/kg, i.p.). Each animal 
was placed on a stereotaxic device (Narishige Scientific 
Instrument Laboratory, Tokyo, Japan) and artificially ven-
tilated using a small animal respirator (Model 683, Rodent 
Ventilator, Harvard, Holliston, MA, USA). Levels of CO2 
in expired air were maintained within the physiological 
range using a capnometer (Model 2200, Traverse Medical 
Monitors, Saline, MI, USA). Somatosensory evoked poten-
tials (SSEPs) were recorded to measure the conduction re-
covery of the sensory system. A special electrode (NE-120, 
Rhodes Medical Instruments, Inc., Woodland Hills, CA, 
USA) was used for SSEP recording. For the SSEP record-
ing, the recording electrode was placed in the sensorimotor 
cortex (bregma: －2 mm, lateral: 2 mm; recording side). A 
bipolar platinum wire electrode placed in the contralateral 
sciatic nerve (stimulating side) was used as a stimulating 
electrode. 
  Motor evoked potentials (MEPs) were recorded to meas-
ure the conduction recovery of the motor system. Special 
electrodes that were identical to the SSEP recording elec-
trodes wereused to stimulate the motor cortex (stimulating 
side). Laminectomy was performed at the L1 spinal cord 
for the placement of the recording electrodes. Following the 
laminectomy, the same special electrode was inserted into 
the contralateral gray matter of the L1 spinal cord (recor-
ding side) to record MEPs. 
  A single square pulse (0.1 ms duration) of electrical stim-
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Fig. 1. Behavioral effects of hMSC transplantation. The behavior 
in hemisected rats without transplantation (n=19), with polymer 
transplantation (n=21), and with polymer combined with hMSC 
transplantation (n=22) was tested before hemisection surgery and 
after 1 d, 4 d, and once a week from one to eight weeks after 
hemisection surgery. (A) The polymer and hMSC-transplanted 
group significantly improved hindlimb performance in injured (left) 
legs at five weeks after transplantation. (B) In injured (left) hind-
limb, the PWT was significantly different at five and eight weeks 
after transplantation (↓ or ↑: hemisection or transplantation 
time, *p＜0.05). 
ulus was delivered by a stimulus isolator (A365D, World 
Precision Instruments, Inc., New Haven, CT, USA) that 
was driven by a pulse generator (Pulsemaster A300, World 
Precision Instruments). The analog signals of the evoked 
potentials were amplified (×10,000), filtered (bandpass 300
∼1,000 Hz), and fed to an IBM-compatible PC through an 
AD/DA converter (CED 1401, Cambridge, UK) to be aver-
aged using Spike 2 software. Each SSEP or MEP consisted 
of an average of 100∼300 single sweep epochs. The effect 
of the stimulation intensity on SSEPs or MEPs was ana-
lyzed in the wave forms by latencies and amplitudes.
X-gal-positive cell counts
  Eight weeks after transplantation, the rats were sacri-
ficed and perfused with normal saline and 4% paraformal-
dehyde. The spinal cords were removed and post-fixed for 
24 h followed by incubation in 30% sucrose overnight. The 
spinal cord was longitudinally sectioned by cryostat (10 μm 
thickness: Microm/HM500V, Walldorf, Germany) and the 
specimens were stored at －20oC. For the detection of β-ga-
lactosidase activity in the spinal cord tissue, fresh frozen 
sections stained with X-gal reagent (5-bromo-4-chloro-3-in-
dolyl-β-d-galactopyranoside in dimethylformamide) were 
stored in a 37oC thermostat container overnight to produce 
a blue color in β-galactosidase-expressing cells. Five slides 
from each of four animals were used for counting X-gal-pos-
itive cells. The number of X-gal-positive cells was counted 
in a 9-mm long section of tissue, within 3 mm around the 
injury region site. 
Immunohistochemical studies
  Immunohistochemistry was performed to evaluate the 
morphological features of transplanted cells in vivo. The 
sections were fixed in 4% paraformaldehyde and rinsed 
with PBS. Blocking solution (PBS containing 0.3% Triton 
X-100, 5.0% bovine serum albumin, 3.0% normal donkey 
serum) was used to treat the sections. The sections were 
incubated with primary antibodies at 4oC overnight. The 
following primary antibodies were used: anti β-galactosi-
dase (1：100, Biogenesis, Kingston, NH, USA), anti-GFAP 
(glial fibrillary acidic protein, astrocytes, 1：100, BD Bio-
sciences, San Jose, CA, USA), anti-Tau (neurons, 1：50, 
Abcam, Cambridge, UK), or anti-APC (mature oligodendro-
cytes, 1：50, Chemicon, Temecula, CA, USA). Secondary 
antibodies, Cy3 (β-galactosidase, 1：500, Jackson, West 
Grove, PA, USA) and FITC (GFAP, Tau, APC, 1：250, 
Jackson, West Grove, PA, USA) were applied to the sections 
for three hours. The sections were mounted with fluo-
rescent mounting medium (Vector, Burlingame, CA, USA) 
and observed by confocal microscope (LSM 510, Zeiss, 
Gottingen, Germany).
Statistical analyses 
  Data are expressed as mean±SEM. One-way ANOVA fol-
lowed by Dunnett’s post-hoc multiple comparison test was 
used to evaluate the behavioral, electrophysiological and 
immunohistochemistry results to compare the hemisection- 
only group with the polymer group or the polymer with 
hMSC-transplanted group. 
RESULTS
Behavioral Improvement after Cell Transplantation 
  Hindlimb performance was tested in all rats using BBB 
open field scaling [32]. The hemisection-only group (n=19) 
scored 0 at 1 day after post injury and the score gradually 
increased to a final score of 7.8±0.7 on the injured leg side 
eight weeks after injury (Fig. 1A). The polymer-only and 
polymer with hMSC-transplanted groups showed improved 
hindlimb performance at five weeks after transplantation 
compared to the hemisection-only group. The mean BBB 
score of the polymer-only group (n=21) was 8.6±0.5. The 
polymer with hMSC-transplanted group (n=22) was 9.7±0.5 
and showed a significantly improved hindlimb performance 
at four weeks after transplantation compared to the hemi-
section-only group. Even though the polymer with hMSC- 
transplanted group showed significantly improved hin-
dlimb recovery over time, there were no differences when 
compared with the polymer-only group. 
  The time course of changes in PWT of hemisection-only, 
polymer transplantation and polymer with hMSC trans-
plantation group is shown in Fig. 1B. After hemisection of 
the left spinal cord at T11, the PWT values to von Frey 
filament stimulation showed a remarkable decrease on the 
injury side of the hind paw as compared with the pre-hemi-
section value in all groups. The PWT of the polymer with 
hMSC-transplanted group was increased compared with 
the hemisection-only group starting at three weeks after 
transplantation. And on injured leg side, the PWT was sig-
nificantly different at five and eight weeks after transplan-
tation. 
Recovery of neural conduction 
  Electrophysiological measurements of SSEPs and MEPs 
activity were used to determine if axons conducting sensory 
and/or motor information crossed the damage site during 
the recovery period (Figs. 2 and 3). The SSEPs were re-
corded in the sensorimotor cortex following stimulation of 
the sciatic nerve. Fig. 2A shows representative wave forms 
of SSEPs by 6 mA stimulation in different experimental 
groups. When the sciatic nerve was stimulated, a neg-
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Fig. 5. Double staining of β-gal and Tau, GFAP or APC analyzed 
by confocal microscopy. (A, D, G) β-gal-positive cells. (B, E, H) Tau, 
GFAP, APC-positive cells. (C, F, I) merged. 
Fig. 3. In vivo electrophysiological effects of hMSCs transplan-
tation. (A, B) Latencies and amplitudes of SSEPs. The P1-peak 
latencies in polymer with hMSC group were shorter than that with 
the hemisection group on the injured side (A). (C, D) Latencies and 
amplitudes of MEPs. P1-peak amplitudes in polymer with hMSC 
were significantly higher than in hemisection group on the injured 
side (C). Asterisks indicate statistically significant differences 
compared to the hemisection-only group, based on Dunnett's post- 
hoc multiple comparison test (*p＜0.05). 
Fig. 2. Representative wave forms of somatosensory evoked poten-
tials (A), and motor evoked potentials (B) at different intensity 
stimulations.
Fig. 4. Staining with X-gal. (A) X-gal-positive cells were observed 
around the injury site and in adjacent sites, indicating that trans-
planted cells had migrated. (B∼D) High magnification of box B, 
C, D in A (arrowhead: X-gal positive cells). (E) The number of 
X-gal-positive cells along the whole section (rostral, injured, and 
caudal sites). 
ative-positive-negative deflection with a short latency was 
observed at the sensorimotor cortex. The latencies of the 
SSEPs were classified as initial, N1- and P1-peak latencies. 
The latency of the polymer-only group and polymer with 
hMSC group on the injured side was shorter than that of 
the hemisection-only group. Especially, the P1-peak latency 
of polymer with the hMSC-transplanted group was sig-
nificantly shorter than that of the hemisection-only group 
(Fig. 3A). The amplitudes of polymer with the hMSC group 
tended to increase as compared with those of the hemi-
section-only group, but there was no significant difference 
(Fig. 3B). 
  The MEPs were recorded using a bipolar disk electrode 
in the L1 spinal cord after stimulation of the hindlimb area 
of the sensorimotor cortex. Fig. 2B shows representative 
wave forms of the MEPs recorded in the hemisection, poly-
mer and polymer with hMSC transplanted animals. The 
wave forms were very similar to SSEPs as negative-pos-
itive-negative deflection. After spinal hemisection injury, 
the animals showed lengthened MEP latencies and reduced 
amplitudes. In the MEPs, the latency of polymer with the 
hMSC-transplanted group tended to be short compared to 
that with the hemisection-only group, but there was no sig-
nificant difference (Fig. 3C). In amplitudes, the P1-peak 
amplitudes of the polymer with hMSC transplanted group 
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were significantly increased compared to those of the hemi-
section-only group (Dunnett’s post-hoc multiple comparison 
test, p＜0.05) (Fig. 3D). However, there was no difference 
between the polymer only- and polymer with hMSC-trans-
planted groups. Therefore, the improvement in SSEPs and 
MEPs may indicate that the damaged axons had recovered 
to conduct the action potentials following polymer with 
hMSC-transplantation.
Immunohistochemical evidence to support survival 
and differentiation patterns of transplanted cells 
  We determined the exogenous hMSC cell survival and 
amounts of settled cells by X-gal staining (Fig. 4). The 
X-gal-positive cells appeared in the injury site and in ad-
jacent sites to the spinal cord (Fig. 4A-D). The number of 
positive cells is summarized in Fig. 4E. The number of 
X-gal-positive cells in the rostral site, injured site and cau-
dal site were 25.5±3.48, 7.3±1.78 and 29.6±3.9, respectively, 
along the whole section (Fig. 4E). Therefore, these data in-
dicate that the polymer with hMSC transplanted cells mi-
grated to rostral and caudal sites, even though the cells 
were transplanted in the hemisected area. 
  Immunoreactivity of β-galactosidase (β-gal) was obser-
ved by confocal microscopy in the injured site at eight 
weeks after transplantation, which indicates that trans-
planted hMSCs have successfully been grafted into the spi-
nal cord. The double staining of β-gal and Tau, β-gal and 
GFAP, or β-gal and APC-positive cells was present in the 
transplanted site and in adjacent sites, indicating that 
some of the transplanted cells had settled and differ-
entiated into neurons, astrocytes or oligodendrocytes (Fig. 
5), although the number of differentiated cells was very low. 
DISCUSSION
  In this study, we observed that the transplantation of pol-
ymer with hMSCs into the spinal cord after a hemisection 
injury results in improved functional outcomes as de-
termined by behavioral tests, electrophysiology and im-
munostaining analyses. Previous reports suggest that 
MSCs can promote functional recovery when grafted into 
contusion injury models [23,24,28,31], which is in agree-
ment with the results of our study. The results of hindlimb 
performance assessments showed significantly improved 
functional outcomes at five weeks after injury in subjects 
that received transplantations of polymer with hMSC. 
Although there were no significant differences, the function 
of injured hindlimbs of the polymer-transplanted group 
tended to show improvement compared to the hemisec-
tion-only group. Therefore the polymer may have the ca-
pacity to provide an axonal guiding bridge and improve 
functional recovery in a hemisection model, even without 
transplantation of MSCs. 
  The hemisection model used in this study produced some-
what severe injury compared to the other models, by elimi-
nating 3 mm thick of the spinal cord. So it might have low 
BBB scores than the other models given light hemisection 
injury among those studies reported previously. Similar 
BBB scores can be found in a study using similar hemi-
section model [34]. SCI induces the loss of sensory and mo-
tor function and the development of chronic pain in the ma-
jority of patients. SCI-induced pain is characterized as 
spontaneous burning pain, allodynia and hyperalgesia, all 
of which occur at or below the level of the lesion [35,36]. 
Hindpaw withdrawal thresholds to von Frey stimulation 
decrease after spinal contusion, indicating that mechanical 
allodynia develops below the level of the injury [37]. In 
agreement with the results of a study by Yoon et al. [37], 
our results also showed that spinal hemisection injury de-
creases the PWT to mechanical allodynia. The PWT values 
of polymer with hMSCs-transplanted rats increased at five 
weeks after transplantation and were significantly increa-
sed in comparison to PWT values in the hemisection-only 
group. This indicates that the transplantation of polymer 
with hMSC is more effective than the transplantation of 
polymer only for functional recovery, and this difference 
may be due to the ability of the polymer to form a bridge 
across the trauma cavity and provide a supportive environ-
ment for survival and differentiation of transplanted hMSC 
cells. While there have been several reports demonstrating 
behavioral improvement, few have shown evidence of con-
duction recovery. Normal rats show a reflexive withdrawal 
when they are stimulated with 20 g of von Frey as the re-
sult of this study. About 20 g of stimulation is needed to 
produce a reflex for von Frey filament. Therefore, the 
threshold of the stimulation is low owing to the pain but 
not a reflex reaction. Thus, we might guess lowered paw 
withdrawal threshold is for pain.
  Our electrophysiological results demonstrate that sub-
jects that received transplantations of polymer with hMSC 
had a shorter SSEP latency, which is consistent with our 
behavioral results and with our previous study in which 
hMSC transplantation reduced the pain and recovered the 
conduction in contusion SCI [31]. Functional recovery in-
cludes sensory as well as motor components. Behavioral 
tests in our study showed that somatosensory as well as 
locomotor performance was improved after polymer with 
hMSC transplantation. The SSEPs and MEPs may have 
improved because the damaged neurons and axons had re-
covered to conduct the action potentials after polymer with 
hMSC transplantation. In the injured spinal cord, there is 
neuron demyelination as well as neuronal cell death. Many 
studies have reported axonal regeneration and remyelina-
tion following transplantation of various cells. When di-
rectly injected into demyelinated rat spinal cord, marrow 
cells derived from the mononuclear layer can remyelinate 
these axons [38]. In animal models of SCI, grafts of MSC 
have been shown to promote remyelination [39] as well as 
partial recovery of function [23,24,40]. Consequently, re-
connection and remyelination of axons in the injured spinal 
cord might be easier after the transplantation of the poly-
mer with hMSC. 
  We used β-gal to observe survival and differentiation 
patterns of transplanted cells. The extent of cells that have 
settled and survived after the transplantation was de-
termined by observing β-gal positive in longitudinal sec-
tions of the spinal cord including the hemisected injury site 
at eight weeks after transplantation. The hMSCs trans-
planted into the hemisection cavity had also migrated from 
the injured site to rostral and caudal sites. This result in-
dicates that the transplantation of polymer with hMSCs re-
sults in successful implantation, with the polymer playing 
an important role in connection within the cavity site. Lu 
and colleagues [41] mentioned that MSCs also migrate for 
short distances from the lesion site into the host tissue. 
  In previous studies, MSCs have been shown to differen-
tiate into cells with neural characteristics in vivo [22,23,42]. 
MSCs can differentiate into astrocytes when transplanted 
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into rodent brain and neurons in vitro, under the appro-
priate cell culture conditions [43]. Our immunohistochemis-
try data also supports these results from previous studies. 
After double staining, we observed that the transplanted 
hMSCs were coated with β-gal and Tau, GFAP or APC 
in the transplanted and the adjacent sites, indicating that 
the transplanted cells had settled and differentiated into 
neurons, astrocytes and oligodendrocytes. Tau and APC 
seem equal to β-gal (red) in transplanted cells as it is 
stained in internal part of the cell cytoplasm due to the 
nature of staining. However β-gal shows round shape (red) 
as exists in internal part of cytoplasm infected with viruses 
into the transplanted cells while GFAP-positive staining 
(green) seems different as it stained external part of mem-
brane surrounding cytoplasm. Therefore, it is shown by 
staining of external (GFAP-positive fibers) and internal 
(cytoplasm) parts on the basis of cell body. Therefore, our 
data demonstrate that the transplanted polymer with 
hMSCs results in differentiation of the hMSCs into a varie-
ty of cell-types and successful functional recovery and 
bridge generation for axonal recovery, resulting in im-
proved behavioral performance and neural conduction. 
  Neurotrophins released from grafts or provided exoge-
nously have a neuroprotective effect due to the decrease 
in retrograde degenerative changes in axotomized neurons 
[44-46]. Therefore, we hypothesize that the specific combi-
natorial treatment of polymer delivery with the secreted 
factors produced by MSCs may improve recovery in a hemi-
section model. There is growing evidence that MSCs pro-
duce a variety of neurotrophic factors as well as chemokines 
and cytokines in vitro and in vivo [47]. In the present study, 
we did not study the secretion produced by hMSC. However, 
recovery of damaged neurons and axons, and remyelination 
may be due to secretion from hMSCs as well as to the direct 
effect of polymer combined with hMSC. Thus, our results 
suggest that polymer with hMSCs may be useful as a com-
binatorial repair approach to treating SCI.
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